Drugs for Relapse Prevention of Alcoholism
Alcoholism is a pathological behavioural syndrome, characterised by comp- sive alcohol use, craving and relapses, even recurring after many years of abstinence. It is suggested that chronic alcohol abuse leads to persistent changes within several neurochemical pathways in the brain and furthermore t...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Basel :
Birkhäuser Basel,
2005.
|
| Σειρά: | Milestones in Drug Therapy MDT
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- History of prevention of relapse
- How to measure relapse in animals
- How to measure relapse in humans
- Disulfiram (Antabuse®): the first medication to stop drinking
- Naltrexone: preclinical data
- Naltrexone: clinical data
- Acamprosate: preclinical data
- Acamprosate: clinical data
- Serotonergic compounds: preclinical data
- Serotonergic compounds: clinical data
- Opioidergic compounds: preclinical data
- Second generation opioidergic compounds: clinical data
- Dopaminergic compounds: preclinical data
- Dopaminergic compounds: clinical data
- Baclofen: preclinical data
- Baclofen: clinical data
- Cannabinoid receptor antagonists: a perspective
- Neuropeptide Y antagonists: a perspective
- Glutamatergic compounds: a perspective
- Future perspectives on relapse prevention.
